Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kumiko Kusumoto"'
Autor:
Makiko Motoi-Ohtsuji, Hisakazu Iwai, Kunihiro Ohta, Jun Katagi, Tadayoshi Ueda, Motoharu Kakiki, Takuo Ogihara, Takuya Nagao, Sho Tanaka, Kumiko Kusumoto, Norihito Matsumoto, Daichi Nagai, Hiroshi Arakawa, Takako Ohkura, Shinya Kaneda, Emiko Ozeki, Tomoko Jomura, Yukiko Inoue
Publikováno v:
Fundamental Toxicological Sciences. 2:41-48
Autor:
Nobuhiko Miwa, Hiroshi Tanaka, Kumiko Kusumoto, Naoko Yoshimura, Ryoko Asada, Katsuhiro Kageyama
Publikováno v:
Life Sciences. 80:1851-1855
New delta-alkyllactones (DALs) with diverse side-chain lengths (184–254 Da), which are structurally different from the widespread, naturally occurring delta-lactones of higher molecular weight (348–439 Da), such as camptothecin and sultriecin, we
Autor:
Tadayoshi Ueda, Hisakazu Iwai, Takeshi Ikeya, Takuo Ogihara, Takuya Nagao, Naoki Takahashi, Yukiko Inoue, Hiroshi Arakawa, Kumiko Kusumoto, Kazushi Naitoh, Emiko Ozeki, Kunihiro Ohta, Takako Ohkura, Kazuki Wada, Akiko Koeda, Tomoko Jomura
Publikováno v:
Drug metabolism and pharmacokinetics. 29(5)
We investigated the utility of three-dimensional (3D) spheroid cultures of human hepatocytes in discovering drug metabolites. Metabolites of acetaminophen, diclofenac, lamotrigine, midazolam, propranolol and salbutamol were analyzed by liquid chromat
Publikováno v:
Oncology Reports.
Alkylolides and alkenylolides of 198-254 Da such as hexadecan-16-olide and 9-hexadecen-16-olide were chemically synthesized in the present study as new macrocyclic lactones that are structurally different from widespread natural macrocyclic lactones
Publikováno v:
Oncology Reports.
Diverse omega-hydroxy fatty acids (omegaHFAs) and their derivatives were examined for their ability to diminish the cell viability of Ehrlich ascites tumor cells by the mitochondrial dehydrogenase-based WST-1 assay and trypan blue dye exclusion assay
Publikováno v:
Oncology reports. 11(4)
Diverse omega-hydroxy fatty acids (omegaHFAs) and their derivatives were examined for their ability to diminish the cell viability of Ehrlich ascites tumor cells by the mitochondrial dehydrogenase-based WST-1 assay and trypan blue dye exclusion assay